Viagra Investigator Among New Members Of FDA Reproductive Health Cmte.
Executive Summary
Lead investigator for Viagra clinical trials William Steers joins FDA's Reproductive Health Drugs Advisory Committee as one of four new members
You may also be interested in...
Study Involvement Is Not Conflict For Advisory Cmte Members – FDA’s Temple
Conducting clinical trials for a manufacturer generally does not pose a conflict of interest risk for advisory committee members, FDA Office of Medical Policy Director Robert Temple said Aug. 23
COX-2 Advisory Cmte. Was Unbiased Crawford Says; Conflict Policy To Stay
FDA may consider having an ethics counselor present at the start of advisory committee meetings as part of an agency plan to reduce potential conflicts of interest, although the current policy will largely remain intact
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011